MESA, ARIZONA / ACCESS Newswire / September 22, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a significant innovation in dermatological AI: a platform capable of detecting squamous cell carcinoma (SCC), the second most common skin cancer and a condition responsible for more than 15,000 deaths annually in the United States alone. Early SCC detection is critical, as the cancer can spread to lymph nodes and distant organs if untreated. ...

Core Insights - Integra LifeSciences Holdings Corporation has appointed Dr. Raymond Turner as the new corporate vice president and chief medical officer [1] - Dr. Turner brings over 20 years of experience in clinical operations from leading global MedTech companies and will oversee worldwide medical affairs and clinical development at Integra [2][3] - The appointment is expected to enhance Integra's focus on building robust clinical evidence and improving patient care [3][4] Company Overview - Integra LifeSciences is dedicated to restoring patients' lives through innovative treatment pathways and high-quality medical technology [6] - The company aims to set new standards in surgical, neurologic, and regenerative care [6] Dr. Raymond Turner's Background - Dr. Turner has held senior leadership roles at Siemens Healthineers and Cerenovus, and has extensive experience in neurosurgery [3][5] - He has authored over 150 peer-reviewed publications and participated in more than 70 pre-clinical and clinical research studies [5]

Accomplished innovator and healthcare executive brings proven strategic leadership and expertise in scaling high-growth healthcare companiesSUNNYVALE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell” or the “Company”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced the appointment of Erica Rogers to its Board of Directors. Ms. Rogers brings over three decades of experience ...

Core Insights - BD (Becton, Dickinson and Company) has announced a pharmacy automation partnership with Henry Ford Health to create a future-oriented pharmacy system, focusing on a robotic solution for 24/7 prescription pickup [1][2]. Group 1: Partnership Details - The collaboration will utilize the BD Rowa™ Vmax, a high-capacity pharmacy automation robot, to improve prescription retrieval processes at Henry Ford Health's community pharmacies in Southeast and Central Michigan [2][3]. - This partnership aims to enhance patient-centered care and innovation within the health system pharmacy [3][4]. Group 2: Benefits of Automation - The BD Rowa™ Vmax is designed for high-speed, modular storage and dispensing of medications, which will improve patient access to prescriptions and streamline pharmacy operations [3][6]. - Key benefits include 24/7 prescription access, real-time tracking, and improved efficiency for pharmacy staff, allowing them to focus on higher-value patient care tasks [6][4]. Group 3: Company Overview - BD is one of the largest global medical technology companies, dedicated to advancing health through innovative technologies and solutions that enhance clinical therapy and care delivery [5][7]. - The company employs over 70,000 individuals and collaborates globally to address significant health challenges, aiming to improve outcomes and lower costs in healthcare [5][7].

Group 1 - Becton, Dickinson and Company (BDX) is recognized as a medical technology company currently undergoing a turnaround due to past challenges, including strategic missteps and a significant product recall [2][3] - The company has acquired the critical care product group from Edwards Lifesciences to enhance its core business and plans to spin off its biosciences and diagnostic solutions division, which is set to be purchased by Waters in a deal expected to close by 2026 [3] - BDX has a strong dividend history, with a 53-year track record of consistent payments, offering a quarterly dividend of $1.04 per share and a dividend yield of 2.22% as of September 19 [5] Group 2 - The planned spinoff of the biosciences and diagnostic solutions division is projected to be accretive to earnings in its first year, suggesting that the dividend should remain stable throughout the transition [4]

Company Overview - STRATA Skin Sciences, Inc. is a medical technology company focused on developing and commercializing products for dermatological conditions, utilizing expertise in laser technology [1] Financial Performance - STRATA's Return on Invested Capital (ROIC) is -58.59%, while its Weighted Average Cost of Capital (WACC) is 7.71%, resulting in a ROIC to WACC ratio of -7.60, indicating inefficiencies in capital utilization [2] - Comparatively, Sensus Healthcare, Inc. has a ROIC of -4.47% and a WACC of 10.28%, leading to a ROIC to WACC ratio of -0.44, which is the highest among its peers, suggesting better capital efficiency [3] - Other peers like Soleno Therapeutics, Inc. and SenesTech, Inc. have ROIC to WACC ratios of -13.40 and -12.05, respectively, indicating significant challenges in generating returns above their cost of capital [4] - Xcel Brands, Inc. also faces issues with a ROIC to WACC ratio of -8.94, highlighting inefficiencies in capital management [4] - Overall, all companies, including STRATA, are struggling to generate returns above their cost of capital, with Sensus Healthcare standing out for its relatively better performance [5]

MESA, ARIZONA / ACCESS Newswire / September 19, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a pioneer in AI-powered diagnostics, today unveiled its breakthrough artificial intelligence platform for the detection and monitoring of basal cell carcinoma (BCC), the most common form of skin cancer. Though rarely fatal, untreated BCC can cause severe disfigurement, local tissue invasion, and costly surgeries. ...

Accessibility StatementSkip Navigation Leading breast surgical oncologist Dr. Amelia Tower to present on wide-field optical coherence tomography for margin visualization during breast conserving surgery TORONTO and DALLAS, Sept. 19, 2025 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced that Dr. Amelia Tower, a leading breast surgical oncologist will present today at the 2025 Annual Clinica ...

MESA, ARIZONA / ACCESS Newswire / September 18, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a leader in AI-powered preventive healthcare, today announced a major advancement in dermatology: an artificial intelligence platform designed to revolutionize the early detection of melanoma, the deadliest form of skin cancer. Melanoma accounts for only 1% of skin cancers but causes the majority of skin cancer deaths worldwide. ...

Safe Supply Streaming Co Ltd. Secures Canadian Distribution Agreement with NIRLAB SA to Provide Advanced Drug Detection Technology to Indigenous CommunitiesSeptember 18, 2025 7:13 AM EDT | Source: Safe Supply Streaming Co Ltd.Toronto, Ontario--(Newsfile Corp. - September 18, 2025) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) ("Safe Supply" or the "Company"), a pioneer in health and safety, and rapid response technologies, today announced it has signed a Canadian distri ...